Herantis Pharma to Participate in the Upcoming Investor Conferences
Herantis Pharma Plc, Press Release, 3 January 2022 at 12:45 EET Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced that Dr. Craig Cook, Chief Executive Officer, will hold 1x1 meetings and company presentations at the following investor conferences: H.C. Wainwright BioConnect Conference, US - January 10th - 13th, 2022 (Virtual) The presentation will be held on January 10[th] at 14:00 – 14:30 EET / 13:00 – 13:30 CET. 1x1 meetings will be scheduled during January 10-13[th]. Biotech Showcase, US -